Clinical Pharmacology
Welcome to Stellenbosch University

Division of Clinical Pharmacology

Publications 2016

1.  Marks C, van Hoving N, Edwards N, Kanema C, Kapindula D, Menge, Nyadedzor C, Roberts C, Tagwireyi D, Tempowski J. A promising poison information centre model for Africa. African Journal of Emergency Medicine 2016, 6: 64-69


2.  Opladen T, Lindner M, Das AM, Marquardt T, Khan A, Emre SH, Burton BK, Barshop BA, Böhm T, Meyburg J, Zangerl K, Mayorandam S, Bugard P, Dürr UHN, Rosenkranz B, Rennecke J, Derbinski J, Yudkoff M, Hoffmann GF. In vivo monitoring of urea cycle activity with 13C-acetate as tracer of ureagenesis. Molecular Genetics and Metabolism 2016, 117: 19-26.


3.  Thomford NE, Awortwe C, Dzobo K, Adu F, Chopera D, Wonkam A, Skelton M, Blackhurst D, Dandara C. Inhibiton of CYP2B6 by Medicinal Plant Extracts: Implications for use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings. Molecules 2016, 211


4.  Kasten-Hilka T, Abulfathi A, Rosenkranz B, Bennett B, Schwenkglenks M, Sinanovic E. Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis – a systematic review of global literature with focus on South Africa. Health and Quality of Life Outcomes 2016, 14: 42.


5.  Van Zyl GU, Decloedt EH. Is HIV-1C risk factor for protease inhibitor failure? The Lancet 2016.


6.  Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF. Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus 2016 0: 1 – 10.


7.  Kastien-Hilka T, Rosenkranz B, Bennett B, Sinanovic E, Schwenkglenks M. How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis – Designing a Prospective Observational Study in South Africa. Pharmaceutical Medicine and Outcomes Research 2016 7: 1-11.


8.  Visser Kift E, Freeman N, Cook C, Myer L. Retinopathy of prematurity screening criteria and workload implications at Tygerberg Children's Hospital, South Africa: A cross-sectional study. SAMJ 2016 106(6): 602 – 606.


9.  Lewandowksi LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa. Lupus 2016 0: 1 – 9.

10. Abulfathi AA, Greyling T, Makiwane M, Esser M, Decloedt E. Angio-oedema associated with colistin. SAMJ 2016 106(10): 990-991.


11. Patel O, Muller C, Joubert E, Louw J, Rosenkranz B, Awortwe C. Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-D-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs. Molecules 2016 21 1515; doi:10.3390/molecules21111515.

12. Marks CJ, Van Hoving DJ. A 3-year survey of acute poisoning exposures in infants reported in telephone calls made to the Tygerberg Poison Information Centre, South Africa. S Afr J Child Health 2016; 10 (1): 43-46

13. Harmse L, Reuter H. An overview of the biological disease modifying drugs available for arthritic conditions in South Africa. South African Family Practice 2016; 58(6):18-22

14. Decloedt EH, Freeman C, Howells F, Casson-Crook M, Lesosky M, Koutsilieri E, Lovestone S, Maartens G,. Joska JA. Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium. Medicine 2016 95(46): e5401

15. Decloedt EH, Müller GJ. Haemotoxic snakebite in rural KwaZulu-Natal, South Africa. S Afr Med J 2016 106(8): DOI:10.7196/SAMJ.2016.v106i8.11119​